{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T07:04:13Z","timestamp":1767337453852},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2013,11,10]],"date-time":"2013-11-10T00:00:00Z","timestamp":1384041600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tumor Biol."],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1007\/s13277-013-1356-0","type":"journal-article","created":{"date-parts":[[2013,11,9]],"date-time":"2013-11-09T09:44:19Z","timestamp":1383990259000},"page":"2701-2710","source":"Crossref","is-referenced-by-count":14,"title":["The enhanced apoptosis and antiproliferative response to combined treatment with valproate and nicotinamide in MCF-7 breast cancer cells"],"prefix":"10.1007","volume":"35","author":[{"given":"Hanieh","family":"Jafary","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahin","family":"Ahmadian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masoud","family":"Soleimani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,11,10]]},"reference":[{"key":"1356_CR1","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1476-4598-5-8","volume":"5","author":"JP Alao","year":"2006","unstructured":"Alao JP, Stavropoulou AV, Lam EW, Coombes RC, Vigushin DM. Histone deacetylase inhibitor, trichostatin A induces ubiquitin-dependent cyclin D1 degradation in MCF-7 breast cancer cells. Mol Cancer. 2006;5:8.","journal-title":"Mol Cancer"},{"issue":"8","key":"1356_CR2","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1080\/01635581.2012.719658","volume":"64","author":"E Bozkurt","year":"2012","unstructured":"Bozkurt E, Atmaca H, Kisim A, Uzunoglu S, Uslu R, Karaca B. Effects of Thymus serpyllum extract on cell proliferation, apoptosis and epigenetic events in human breast cancer cells. Nutr Cancer. 2012;64(8):1245\u201350.","journal-title":"Nutr Cancer"},{"issue":"1","key":"1356_CR3","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.canlet.2008.03.037","volume":"269","author":"JS Carew","year":"2008","unstructured":"Carew JS, Giles FJ, Nawrocki ST. Histone deacetylase inhibitors: mechanisms of cell death and promise in combination cancer therapy. Cancer lett. 2008;269(1):7\u201317.","journal-title":"Cancer lett"},{"issue":"2","key":"1356_CR4","first-page":"170","volume":"5","author":"M Ageberg","year":"2013","unstructured":"Ageberg M, Rydstrom K, Relander T, Drott K. The histone deacetylase inhibitor valproic acid sensitizes diffuse large B-cell lymphoma cell lines to CHOP-induced cell death. Am J Transl Res. 2013;5(2):170\u201383.","journal-title":"Am J Transl Res"},{"issue":"21","key":"1356_CR5","doi-asserted-by":"crossref","first-page":"9671","DOI":"10.1073\/pnas.1000401107","volume":"107","author":"DA Hsia","year":"2010","unstructured":"Hsia DA, Tepper CG, Pochampalli MR, Hsia EY, Izumiya C, Huerta SB, et al. KDM8, a H3K36me2 histone demethylase that acts in the cyclin A1 coding region to regulate cancer cell proliferation. Proc Natl Acad Sci U S A. 2010;107(21):9671\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"1356_CR6","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1158\/1535-7163.MCT-08-0860","volume":"8","author":"L Ellis","year":"2009","unstructured":"Ellis L, Atadja PW, Johnstone RW. Epigenetics in cancer: targeting chromatin modifications. Mol Cancer Ther. 2009;8(6):1409\u201320.","journal-title":"Mol Cancer Ther"},{"issue":"8","key":"1356_CR7","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.3390\/ph3082441","volume":"3","author":"L Ellis","year":"2010","unstructured":"Ellis L, Pili R. Histone deacetylase inhibitors: advancing therapeutic strategies in hematological and solid malignancies. Pharmaceuticals (Basel). 2010;3(8):2411\u201369.","journal-title":"Pharmaceuticals (Basel)"},{"issue":"4","key":"1356_CR8","first-page":"637","volume":"33","author":"S Emanuele","year":"2008","unstructured":"Emanuele S, Lauricella M, Tesoriere G. Histone deacetylase inhibitors: apoptotic effects and clinical implications (review). Int J Oncol. 2008;33(4):637\u201346.","journal-title":"Int J Oncol"},{"issue":"4","key":"1356_CR9","doi-asserted-by":"crossref","first-page":"e62610","DOI":"10.1371\/journal.pone.0062610","volume":"8","author":"CS Ward","year":"2013","unstructured":"Ward CS, Eriksson P, Izquierdo-Garcia JL, Brandes AH, Ronen SM. HDAC inhibition induces increased choline uptake and elevated phosphocholine levels in MCF7 breast cancer cells. PLoS One. 2013;8(4):e62610.","journal-title":"PLoS One"},{"issue":"2","key":"1356_CR10","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.intimp.2013.04.006","volume":"16","author":"JB Jeong","year":"2013","unstructured":"Jeong JB, Choi J, Lou Z, Jiang X, Lee SH. Patchouli alcohol, an essential oil of Pogostemon cablin, exhibits anti-tumorigenic activity in human colorectal cancer cells. Int Immunopharmacol. 2013;16(2):184\u201390.","journal-title":"Int Immunopharmacol"},{"issue":"11","key":"1356_CR11","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1002\/cbdv.200590118","volume":"2","author":"M Jung","year":"2005","unstructured":"Jung M, Kozikowski A, Dritschilo A. Rational design and development of radiation-sensitizing histone deacetylase inhibitors. Chem biodivers. 2005;2(11):1452\u201361.","journal-title":"Chem biodivers"},{"issue":"6","key":"1356_CR12","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1111\/j.1349-7006.2010.01559.x","volume":"101","author":"R Noro","year":"2010","unstructured":"Noro R, Miyanaga A, Minegishi Y, Okano T, Seike M, Soeno C, et al. Histone deacetylase inhibitor enhances sensitivity of non-small-cell lung cancer cells to 5-FU\/S-1 via down-regulation of thymidylate synthase expression and up-regulation of p21(waf1\/cip1) expression. Cancer Sci. 2010;101(6):1424\u201330.","journal-title":"Cancer Sci"},{"issue":"9","key":"1356_CR13","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1002\/cmdc.200800096","volume":"3","author":"JA Souto","year":"2008","unstructured":"Souto JA, Conte M, Alvarez R, Nebbioso A, Carafa V, Altucci L, et al. Synthesis of benzamides related to anacardic acid and their histone acetyltransferase (HAT) inhibitory activities. ChemMedChem. 2008;3(9):1435\u201342.","journal-title":"ChemMedChem"},{"issue":"12","key":"1356_CR14","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1002\/cncr.21589","volume":"104","author":"G Bug","year":"2005","unstructured":"Bug G, Ritter M, Wassmann B, Schoch C, Heinzel T, Schwarz K, et al. Clinical trial of valproic acid and all-trans retinoic acid in patients with poor-risk acute myeloid leukemia. Cancer. 2005;104(12):2717\u201325.","journal-title":"Cancer"},{"issue":"6","key":"1356_CR15","doi-asserted-by":"crossref","first-page":"731","DOI":"10.2217\/epi.10.62","volume":"2","author":"G Franci","year":"2010","unstructured":"Franci G, Miceli M, Altucci L. Targeting epigenetic networks with polypharmacology: a new avenue to tackle cancer. Epigenomics. 2010;2(6):731\u201342.","journal-title":"Epigenomics"},{"issue":"7","key":"1356_CR16","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.3324\/haematol.2009.008870","volume":"95","author":"M Bartels","year":"2010","unstructured":"Bartels M, Geest CR, Bierings M, Buitenhuis M, Coffer PJ. Histone deacetylase inhibition modulates cell fate decisions during myeloid differentiation. Haematologica. 2010;95(7):1052\u201360.","journal-title":"Haematologica"},{"issue":"25","key":"1356_CR17","doi-asserted-by":"crossref","first-page":"3884","DOI":"10.1200\/JCO.2006.09.4169","volume":"25","author":"W Blum","year":"2007","unstructured":"Blum W, Klisovic RB, Hackanson B, Liu Z, Liu S, Devine H, et al. Phase I study of decitabine alone or in combination with valproic acid in acute myeloid leukemia. J Clin Oncol : off J Am Soc Clin Oncol. 2007;25(25):3884\u201391.","journal-title":"J Clin Oncol : off J Am Soc Clin Oncol"},{"issue":"5","key":"1356_CR18","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/cncr.22891","volume":"110","author":"A Kuendgen","year":"2007","unstructured":"Kuendgen A, Gattermann N. Valproic acid for the treatment of myeloid malignancies. Cancer. 2007;110(5):943\u201354.","journal-title":"Cancer"},{"issue":"Suppl 1","key":"1356_CR19","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00277-005-0026-8","volume":"84","author":"A Kuendgen","year":"2005","unstructured":"Kuendgen A, Knipp S, Fox F, Strupp C, Hildebrandt B, Steidl C, et al. Results of a phase 2 study of valproic acid alone or in combination with all-trans retinoic acid in 75 patients with myelodysplastic syndrome and relapsed or refractory acute myeloid leukemia. Ann Hematol. 2005;84 Suppl 1:61\u20136.","journal-title":"Ann Hematol"},{"issue":"5","key":"1356_CR20","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1002\/cncr.21725","volume":"106","author":"A Morotti","year":"2006","unstructured":"Morotti A, Cilloni D, Messa F, Arruga F, Defilippi I, Carturan S, et al. Valproate enhances imatinib-induced growth arrest and apoptosis in chronic myeloid leukemia cells. Cancer. 2006;106(5):1188\u201396.","journal-title":"Cancer"},{"key":"1356_CR21","doi-asserted-by":"crossref","unstructured":"Federico M, Bagella L. Histone Deacetylase Inhibitors in the Treatment of Hematological Malignancies and Solid Tumors. J Biomed Biotechnol. 2011;2011","DOI":"10.1155\/2011\/475641"},{"issue":"1","key":"1356_CR22","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1365-2141.2008.07426.x","volume":"144","author":"AB Bouzar","year":"2009","unstructured":"Bouzar AB, Boxus M, Defoiche J, Berchem G, Macallan D, Pettengell R, et al. Valproate synergizes with purine nucleoside analogues to induce apoptosis of B-chronic lymphocytic leukaemia cells. Br J Haematol. 2009;144(1):41\u201352.","journal-title":"Br J Haematol"},{"issue":"7255","key":"1356_CR23","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/nature08197","volume":"460","author":"T Finkel","year":"2009","unstructured":"Finkel T, Deng CX, Mostoslavsky R. Recent progress in the biology and physiology of sirtuins. Nature. 2009;460(7255):587\u201391.","journal-title":"Nature"},{"issue":"1","key":"1356_CR24","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1158\/0008-5472.CAN-09-2465","volume":"70","author":"M Galli","year":"2010","unstructured":"Galli M, Van Gool F, Rongvaux A, Andris F, Leo O. The nicotinamide phosphoribosyltransferase: a molecular link between metabolism, inflammation, and cancer. Cancer Res. 2010;70(1):8\u201311.","journal-title":"Cancer Res"},{"issue":"43","key":"1356_CR25","doi-asserted-by":"crossref","first-page":"4619","DOI":"10.1038\/onc.2011.612","volume":"31","author":"V Byles","year":"2012","unstructured":"Byles V, Zhu L, Lovaas JD, Chmilewski LK, Wang J, Faller DV, et al. SIRT1 induces EMT by cooperating with EMT transcription factors and enhances prostate cancer cell migration and metastasis. Oncogene. 2012;31(43):4619\u201329.","journal-title":"Oncogene"},{"issue":"4","key":"1356_CR26","doi-asserted-by":"crossref","first-page":"734","DOI":"10.2174\/138161213804581945","volume":"19","author":"M Cea","year":"2013","unstructured":"Cea M, Cagnetta A, Gobbi M, Patrone F, Richardson PG, Hideshima T, et al. New insights into the treatment of multiple myeloma with histone deacetylase inhibitors. Curr Pharm Des. 2013;19(4):734\u201344.","journal-title":"Curr Pharm Des"},{"issue":"3\u20134","key":"1356_CR27","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.fct.2011.11.012","volume":"50","author":"PF Rezaei","year":"2012","unstructured":"Rezaei PF, Fouladdel S, Hassani S, Yousefbeyk F, Ghaffari SM, Amin G, et al. Induction of apoptosis and cell cycle arrest by pericarp polyphenol-rich extract of Baneh in human colon carcinoma HT29 cells. Food Chem toxicol : Int J publ Br Ind Biol Res Assoc. 2012;50(3\u20134):1054\u20139.","journal-title":"Food Chem toxicol : Int J publ Br Ind Biol Res Assoc"},{"issue":"9","key":"1356_CR28","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1007\/s11626-012-9546-4","volume":"48","author":"M Hafizi","year":"2012","unstructured":"Hafizi M, Bakhshandeh B, Soleimani M, Atashi A. Exploring the enkephalinergic differentiation potential in adult stem cells for cell therapy and drug screening implications. In vitro cellular & developmental biology \u2013 Animal. 2012;48(9):562\u20139.","journal-title":"In vitro cellular & developmental biology \u2013 Animal"},{"issue":"6","key":"1356_CR29","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.toxicon.2011.03.008","volume":"57","author":"Y Zhang","year":"2011","unstructured":"Zhang Y, Yu G, Wang D, Hu Y, Lei W. ERK1\/2 activation plays important roles in the opposite effects of Trichostatin A in non-cancer and cancer cells. Toxicon : Off J Int Soc Toxinol. 2011;57(6):932\u20137.","journal-title":"Toxicon : Off J Int Soc Toxinol"},{"issue":"5","key":"1356_CR30","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/nrclinonc.2013.42","volume":"10","author":"N Azad","year":"2013","unstructured":"Azad N, Zahnow CA, Rudin CM, Baylin SB. The future of epigenetic therapy in solid tumours\u2014lessons from the past. Nat Rev Clin Oncol. 2013;10(5):256\u201366.","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"1356_CR31","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.pharmthera.2013.03.010","volume":"139","author":"L Adwan","year":"2013","unstructured":"Adwan L, Zawia NH. Epigenetics: a novel therapeutic approach for the treatment of Alzheimer\u2019s disease. Pharmacol Ther. 2013;139(1):41\u201350.","journal-title":"Pharmacol Ther"},{"issue":"6","key":"1356_CR32","doi-asserted-by":"crossref","first-page":"813","DOI":"10.3748\/wjg.v19.i6.813","volume":"19","author":"I Koutsounas","year":"2013","unstructured":"Koutsounas I, Giaginis C, Patsouris E, Theocharis S. Current evidence for histone deacetylase inhibitors in pancreatic cancer. World J Gastroenterol : WJG. 2013;19(6):813\u201328.","journal-title":"World J Gastroenterol : WJG"},{"key":"1356_CR33","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1471-2490-12-21","volume":"12","author":"TK Byler","year":"2012","unstructured":"Byler TK, Leocadio D, Shapiro O, Bratslavsky G, Stodgell CJ, Wood RW, et al. Valproic acid decreases urothelial cancer cell proliferation and induces thrombospondin-1 expression. BMC Urol. 2012;12:21.","journal-title":"BMC Urol"},{"issue":"4","key":"1356_CR34","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1253\/circj.CJ-09-0580","volume":"74","author":"YK Cho","year":"2010","unstructured":"Cho YK, Eom GH, Kee HJ, Kim HS, Choi WY, Nam KI, et al. Sodium valproate, a histone deacetylase inhibitor, but not captopril, prevents right ventricular hypertrophy in rats. Circ J : Off J Jap Circ Soc. 2010;74(4):760\u201370.","journal-title":"Circ J : Off J Jap Circ Soc"},{"key":"1356_CR35","first-page":"47","volume":"7","author":"K Ververis","year":"2013","unstructured":"Ververis K, Hiong A, Karagiannis TC, Licciardi PV. Histone deacetylase inhibitors (HDACIs): multitargeted anticancer agents. Biol: Targets Ther. 2013;7:47\u201360.","journal-title":"Biol: Targets Ther"},{"issue":"8","key":"1356_CR36","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.3748\/wjg.v19.i8.1173","volume":"19","author":"I Koutsounas","year":"2013","unstructured":"Koutsounas I, Giaginis C, Theocharis S. Histone deacetylase inhibitors and pancreatic cancer: are there any promising clinical trials? World J Gastroenterol : WJG. 2013;19(8):1173\u201381.","journal-title":"World J Gastroenterol : WJG"},{"issue":"3","key":"1356_CR37","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2174\/138945010790711923","volume":"11","author":"J Hrebackova","year":"2010","unstructured":"Hrebackova J, Hrabeta J, Eckschlager T. Valproic acid in the complex therapy of malignant tumors. Curr Drug Targets. 2010;11(3):361\u201379.","journal-title":"Curr Drug Targets"},{"issue":"7","key":"1356_CR38","doi-asserted-by":"crossref","first-page":"e22739","DOI":"10.1371\/journal.pone.0022739","volume":"6","author":"M Cea","year":"2011","unstructured":"Cea M, Soncini D, Fruscione F, Raffaghello L, Garuti A, Emionite L, et al. Synergistic interactions between HDAC and sirtuin inhibitors in human leukemia cells. PLoS ONE. 2011;6(7):e22739.","journal-title":"PLoS ONE"}],"container-title":["Tumor Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-013-1356-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13277-013-1356-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-013-1356-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T05:28:05Z","timestamp":1564637285000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13277-013-1356-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11,10]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["1356"],"URL":"https:\/\/doi.org\/10.1007\/s13277-013-1356-0","relation":{},"ISSN":["1010-4283","1423-0380"],"issn-type":[{"value":"1010-4283","type":"print"},{"value":"1423-0380","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,10]]}}}